Patent ID: 7342022
Filing Date: 2008-03-11
Classification: A61P,C07D

Abstract:
1. A compound which is 3-[7-2(-Methoxyethoxy) quinazolin-4-yl]-2-oxo-2,3-dihydro-1H-indole-5-carboxylic acid (2-oxoazepan-3-yl)amide, 2-Hydroxy-3-[7-(2-methoxyethoxy)quinazolin-4-yl]-1H-indole-5-carboxylic acid [3-(methylphenylamino)propyl]amide, 2-Hydroxy-3-[7-(2-methoxyethoxy)quinazolin-4-yl]-1H-indole-5-carboxylic acid [3-(1-hydroxyethyl)phenyl]amide, 2-Hydroxy-3-[7-(2-methoxyethoxy)quinazolin-4-yl]-1H-indole-5-carboxylic acid (4-cyclohexylphenyl)amide, 2-Hydroxy-3-[7-(2-methoxyethoxy)quinazolin-4-yl]-1H-indole-5-carboxylic acid (4,4-diethoxybutyl)amide, 2-Hydroxy-3-[7-(2-methoxyethoxy)quinazolin-4-yl]-1H-indole-5-carboxylic acid (1H-benzoimidazol-2-ylmethyl)amide, 2-Hydroxy-3-[7-(2-methoxyethoxy)quinazolin-4-yl]-1H-indole-5-carboxylic acid [2-(5-methyl-1H-indol-3-yl)ethyl]amide, 2-Hydroxy-3-[7-(2-methoxyethoxy)quinazolin-4-yl]-1H-indole-5-carboxylic acid 4-sulfamoylbenzylamide or 2-Hydroxy-3-[7-(2-methoxyethoxy)quinazolin-4-yl]-1H-indole-5-carboxylic acid (1-benzylpiperidin-4-yl)amide, as a free base or a salt thereof.